RSS   Newsletter   Contact   Advertise with us
Post Online Media

Anavex Life Sciences adds Peter Donhauser to board

Anavex Life SciencesAnavex Life Sciences Corp., a biopharmaceutical company, announced the appointment of Peter Donhauser to its board of directors.
Dr. Donhauser has more than 20 years of expertise in clinical research followed by practicing osteopathic medicine with an integrated medical approach in private practice since 2000.

Dr. Donhauser worked at the University Hospital of Munich in the fields of geriatrics and neuromusculoskeletal diseases.

During this time, he was a clinical trial investigator in multiple Phase 3 studies, including studies sponsored by Merck Sharp & Dohme/Merck, Boehringer Mannheim/Roche, Servier and Sanofi.

Dr. Donhauser received his human medicine degree at the University of Munich and Doctor of Osteopathic Medicine (D.O.) from the DAAO and EROP at the Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania.

 

 LATEST MOVES FROM New York 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.